Skip to content

PET for Registration of Inflammation in the Vascular wall of Intracranial
 Aneurysms

PET for Registration of Inflammation in the Vascular wall of Intracranial
 Aneurysms - PRIVIA study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON44673
Enrollment
10
Registered
2017-07-11
Start date
2019-01-25
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unruptured intracranial aneurysm

Interventions

Inflammation
Intracranial Aneurysm
Unruptured

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: * Age * 18 year
 * Presence of an unruptured intracranial aneurysm
 * Standard of care decision to treat the aneurysm
 * The aneurysm is surgically accessible
 * Aneurysm wall sampling is deemed possible by the surgeon
 * Written informed consent is obtained

Exclusion criteria

Exclusion criteria: Technical impairments to perform the study
 * Incapacity to lie in prone position for 60 minutes
 * Aneurysm size smaller than PET detection rate (<7 mm)
 * Physical restrictions, e.g. morbid obesity
 * Claustrophobia
 o Evidence of active infection requiring antibiotic therapy
 o Pregnancy or lactation
 o Renal insufficiency (estimated glomerular filtration rate < 60
 ml/min/1.73 m2)
 o Known allergy to gadolinium contrast agent
 o Patients with pacemakers, defibrillators, other implanted electronic
 devices, or possible metal particles
 o Treatment with metformin
 o Multiple myeloma (Kahlers disease)
 o Waldenstrom macroglobulinemia
 o Myasthenia gravis
 o Pheochromocytoma
 o Mastocytosis
 o Thyroid cancer
 o Planned thyroid scan

Design outcomes

Primary

MeasureTime frame
Detection of inflammation by 18F-IL2 PET, related to the gold standard (histopathology/molecular analysis).

Secondary

MeasureTime frame
Analysis of interobserver variability in 18F-IL2 PET interpretation.

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)